The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug ...

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

Semaglutide So Effective at Treating Arthritis That Patients Were “More or Less Were Treated Out of the Study ... who works at the Copenhagen University Hospital in Denmark's capital.

President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland could disrupt one export that is wildly popular in America: Ozempic.

For the new study, Pottegård and his team analyzed data from 44,517 people in Denmark and 16,860 people in Norway, all of whom were eligible for semaglutide for the management of type 2 diabetes.

Patients with type 2 diabetes who use semaglutide have more than double the risk of severe optic nerve damage ... Denmark saw its annual average of first-time NAION cases rise from 67.6 to 148 ...

Bagsværd, Denmark, 21 October 2024— Novo Nordisk today announced the headline results from the SOUL cardiovascular outcomes trial. The double-blinded, randomised trial compared oral semaglutide ...

People who lost a significant amount of weight with semaglutide saw major improvements in osteoarthritis knee pain, ... a professor of rheumatology at the University of Copenhagen in Denmark. ...

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least one related health condition. The once-weekly injectable supports weight loss ...